H. Fai Poon is the Chief Executive Officer of Sirnaomics and a seasoned biotech leader with deep expertise across scientific research, biopharma innovation, and executive management. He is known for guiding organisations through complexity by combining scientific rigor with clear strategic execution.

With leadership experience spanning China, APAC, and the United States, Fai brings a strong global perspective to building high-performing biotech organisations. His career includes founding Quacell, leading cross-border teams, and navigating acquisitions and cultural integration with a people-first mindset grounded in trust, discipline, and accountability.

As CEO of Sirnaomics, Fai leads with a vision centred on patients, patience, and patents, ensuring innovation is both purposeful and sustainable. He balances cutting-edge science with business strategy and organisational execution, creating environments where talented teams can thrive, collaborate, and deliver meaningful breakthroughs in healthcare.